Connect with us

Hi, what are you looking for?

Stock News

Top CAC 40 shares to watch: LVMH, BNP Paribas, Vivendi and more

The CAC 40 Index has come under intense pressure in recent weeks, remaining significantly lower than its year-to-date high of €8,260. It was trading at €7,820 as traders brace for the upcoming European Central Bank (ECB) decision, the August 1 tariff deadline, and top earnings. 

Top CAC 40 Index companies to watch this week

The main catalyst for the CAC 40 Index this week will be corporate earnings by some of the biggest constituent companies. 

LVMH, the biggest company in France, will be the top company to watch as it publishes its financial results. These results will be watched closely because of its size and the impact on the French economy, where luxury brands have a large market share. 

The LVMH stock price has crashed to €475, down by over 37% from its highest point this year and 45% below last year’s high. This crash has brought its market cap to €235 billion, down from over €500 billion a while ago. 

The LVMH earnings will provide more insight into the Chinese economy and whether customers are returning to luxury shopping. Its earnings will also have an impact on other European companies like Kering, Hermes, and L’Oreal. 

Analysts expect the results to show that LVMH earnings per share (EPS) will be €15.11 and its revenues will be €21 billion. 

The other notable CAC 40 Index company to watch is TotalEnergies, one of the world’s largest oil and gas companies, with a market capitalization of over €134 billion. 

These numbers come at a time when the TotalEnergies stock has wavered in the past few weeks. It was trading at €61, a few points below last month’s high of €63.5, and 18% above its lowest point this year.

Its performance is because of the ongoing volatility in the energy market, with the Brent crude oil price hovering at €68, down from the June high of €80. TotalEnergies earnings will likely impact other oil and gas companies like BP and Shell. 

BNB Paribas, Dassault Systemes, and Vivendi

The other notable CAC 40 company to watch this week will be BNP Paribas, one of the biggest banks in the country. Like other European banks, BNP Paribas share price has done well in the past few years, jumping to €79 this month, up by 50% from its lowest point in January. 

BNP Paribas has surged due to its strong earnings growth and dividend payouts to its investors. Its earnings this week will provide more color on the impact of the European Central Bank (ECB) on its revenues and profits.

Dassault Systemes will also be in focus this week as it publishes its financial results. Like LVMH, its stock has been under pressure, falling from €48.20 in January last year to €32 today. These earnings will come a month after it delayed its earnings target timeline to 2029, a sign that its business is struggling.

Further, Vivendi will also be watched as it releases its earnings. These numbers come as its stock surged to a record high following the financial regulator’s rule that Vincent Bollore and his company must make a public offer for shares within the next six months.

The other top CAC 40 Index companies to watch will be Thales, Edenred, Veritas, and Michelin.

The post Top CAC 40 shares to watch: LVMH, BNP Paribas, Vivendi and more appeared first on Invezz

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

    You May Also Like

    Investing News

    Uber is giving commuters new ways to travel and cut costs on frequent rides. The ride-hailing company on Wednesday announced a route share feature on...

    Investing News

    Netflix said Wednesday its cheaper, ad-supported tier now has 94 million monthly active users — an increase of more than 20 million since its last public...

    Investing News

    CAMDEN, N.J. — The father and son duo behind a stock fraud scheme involving the infamous $100 million New Jersey deli were sentenced to...

    Economy News

    President Donald Trump announced on Sunday evening that he would sign an executive order aimed at reducing prescription drug prices in the United States...